LAMIVUDINE\TENOFOVIR: 222 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
222
Total FAERS Reports
6 (2.7%)
Deaths Reported
13
Hospitalizations
222
As Primary/Secondary Suspect
2
Life-Threatening
1
Disabilities
First Report: 20120212 · Latest Report: 20220919
What Are the Most Common LAMIVUDINE\TENOFOVIR Side Effects?
#1 Most Reported
Foetal exposure during pregnancy
74 reports (33.3%)
#2 Most Reported
Virologic failure
71 reports (32.0%)
#3 Most Reported
Viral mutation identified
67 reports (30.2%)
All LAMIVUDINE\TENOFOVIR Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Foetal exposure during pregnancy | 74 | 33.3% | 2 | 0 |
| Virologic failure | 71 | 32.0% | 0 | 0 |
| Pathogen resistance | 67 | 30.2% | 0 | 0 |
| Viral mutation identified | 67 | 30.2% | 0 | 0 |
| Congenital umbilical hernia | 38 | 17.1% | 0 | 0 |
| Exposure during pregnancy | 34 | 15.3% | 1 | 2 |
| Abortion spontaneous | 23 | 10.4% | 0 | 0 |
| Maternal exposure during pregnancy | 21 | 9.5% | 0 | 0 |
| Birth mark | 16 | 7.2% | 0 | 0 |
| Premature delivery | 9 | 4.1% | 0 | 0 |
| Congenital naevus | 8 | 3.6% | 0 | 0 |
| Congenital skin dimples | 8 | 3.6% | 0 | 0 |
| Premature baby | 8 | 3.6% | 1 | 0 |
| Abortion induced | 7 | 3.2% | 0 | 0 |
| Stillbirth | 6 | 2.7% | 0 | 0 |
| Live birth | 5 | 2.3% | 0 | 2 |
Who Reports LAMIVUDINE\TENOFOVIR Side Effects? Age & Gender Data
Gender: 65.5% female, 34.5% male. Average age: 30.0 years. Most reports from: BR. View detailed demographics →
Is LAMIVUDINE\TENOFOVIR Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2012 | 2 | 0 | 0 |
| 2014 | 2 | 0 | 0 |
| 2015 | 1 | 0 | 0 |
| 2016 | 6 | 0 | 0 |
| 2018 | 35 | 2 | 2 |
| 2019 | 13 | 1 | 3 |
| 2020 | 1 | 0 | 0 |
| 2021 | 5 | 0 | 0 |
| 2022 | 4 | 1 | 1 |
What Is LAMIVUDINE\TENOFOVIR Used For?
| Indication | Reports |
|---|---|
| Hiv infection | 172 |
| Product used for unknown indication | 23 |
| Antiretroviral therapy | 10 |
LAMIVUDINE\TENOFOVIR vs Alternatives: Which Is Safer?
LAMIVUDINE\TENOFOVIR vs LAMIVUDINE\TENOFOVIR DISOPROXIL
LAMIVUDINE\TENOFOVIR vs LAMIVUDINE\ZIDOVUDINE
LAMIVUDINE\TENOFOVIR vs LAMOTRIGINE
LAMIVUDINE\TENOFOVIR vs LANADELUMAB
LAMIVUDINE\TENOFOVIR vs LANADELUMAB-FLYO
LAMIVUDINE\TENOFOVIR vs LANREOTIDE
LAMIVUDINE\TENOFOVIR vs LANSOPRAZOLE
LAMIVUDINE\TENOFOVIR vs LANTHANUM
LAMIVUDINE\TENOFOVIR vs LANTUS
LAMIVUDINE\TENOFOVIR vs LANTUS SOLOSTAR
Official FDA Label for LAMIVUDINE\TENOFOVIR
Official prescribing information from the FDA-approved drug label.